ATE30210T1 - Zusammensetzung zur erhoehung des blutdrucks. - Google Patents

Zusammensetzung zur erhoehung des blutdrucks.

Info

Publication number
ATE30210T1
ATE30210T1 AT81902147T AT81902147T ATE30210T1 AT E30210 T1 ATE30210 T1 AT E30210T1 AT 81902147 T AT81902147 T AT 81902147T AT 81902147 T AT81902147 T AT 81902147T AT E30210 T1 ATE30210 T1 AT E30210T1
Authority
AT
Austria
Prior art keywords
blood pressure
composition
increase blood
patient
nervous system
Prior art date
Application number
AT81902147T
Other languages
English (en)
Inventor
Richard J Wurtman
Original Assignee
Richard J Wurtman
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richard J Wurtman filed Critical Richard J Wurtman
Application granted granted Critical
Publication of ATE30210T1 publication Critical patent/ATE30210T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/14Alkali metal chlorides; Alkaline earth metal chlorides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT81902147T 1981-07-15 1981-07-15 Zusammensetzung zur erhoehung des blutdrucks. ATE30210T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/US1981/000964 WO1983000285A1 (en) 1981-07-15 1981-07-15 Process and composition for increasing blood pressure
EP81902147A EP0083338B1 (de) 1981-07-15 1981-07-15 Zusammensetzung zur erhöhung des blutdrucks

Publications (1)

Publication Number Publication Date
ATE30210T1 true ATE30210T1 (de) 1987-10-15

Family

ID=22161323

Family Applications (1)

Application Number Title Priority Date Filing Date
AT81902147T ATE30210T1 (de) 1981-07-15 1981-07-15 Zusammensetzung zur erhoehung des blutdrucks.

Country Status (5)

Country Link
EP (1) EP0083338B1 (de)
JP (1) JPS58501118A (de)
AT (1) ATE30210T1 (de)
DE (1) DE3176479D1 (de)
WO (1) WO1983000285A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5096712A (en) * 1990-03-06 1992-03-17 Interneuron Pharmaceuticals, Inc. Method for enhancing performance so as to improve vigor and decrease fatigue, confusion, tension, and anxiety

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2034543A1 (en) * 1969-02-13 1970-12-11 Etd Experimentales Centre L-tyrosine contg compsn in glucose for - treating fatigue syndrome
US3651237A (en) * 1970-02-11 1972-03-21 Experimentales Et Cliniques De Treating of aggression and reduction of fatigue syndromes with l-tyrosine
US4224343A (en) * 1979-04-05 1980-09-23 Massachusetts Institute Of Technology Process and composition for decreasing blood serum prolactin levels
US4296119A (en) * 1978-04-24 1981-10-20 Massachusetts Institute Of Technology Process and composition for reducing blood pressure in animals
EP0005058B1 (de) * 1978-04-24 1984-10-17 Massachusetts Institute Of Technology Zusammensetzung zur Regulierung des Dopamin- oder Norepinephrin-Spiegels in Neuronen-Synapsen
US4327112A (en) * 1978-04-24 1982-04-27 Massachusetts Institute Of Technology Process for increasing blood pressure

Also Published As

Publication number Publication date
JPS58501118A (ja) 1983-07-14
EP0083338A4 (de) 1984-09-19
WO1983000285A1 (en) 1983-02-03
DE3176479D1 (en) 1987-11-19
EP0083338A1 (de) 1983-07-13
EP0083338B1 (de) 1987-10-14

Similar Documents

Publication Publication Date Title
DE69003392D1 (de) Dosisform zur oralen verabreichung des hypoglykämischen glipizids.
DE68910159D1 (de) Dosierform für Verabreichung in der Humanmedizin.
DK0913156T3 (da) Anvendelse af aktiveret protein C til behandling af hyperkoagulationstilstande i forbindelse med sepsis
ES2137948T3 (es) Sistema avanzado de administracion de medicamentos y metodo de tratamiento de trastornos psiquiatricos, neurologicos y otros con carbamacepina.
BG60253B1 (bg) Човешки тъканен плазминогенен активатор
ATE199643T1 (de) Therapeutisches kombinationspräparat enthaltend interferon
KR880012218A (ko) 캘폰 유도체를 사용한 다발성 경화증의 치료방법
GR76810B (de)
ES2119411T5 (es) Combinaciones de proteinas y anticoagulantes tromboliticamente activos, y usos de los mismos.
EP0879056A4 (de) Modalation der th1/th2 cytokinexpression durch ribavirin-m(3) und ribavirin-(m3) analogen in aktivierten t-lymphozyten
KR950007848A (ko) (S)-(-)-α-에틸-2-옥소-1-피롤리딘아세트아미드를 사용한 불안치료방법
FI883688A0 (fi) Molekylaer kloning och expression av humant interleukin-3.
JPS56104815A (en) Remedy for peripheral orthostatic hypotension
KR910005858A (ko) 지방산 요법
KR910700069A (ko) Gm-csf를 사용한 백혈구 기능장애의 치료
PT651654E (pt) Utilizacao de um dimero de lisozima para a preparacao de um medicamento para modular os mecanismos natutais de defesa
ATE30210T1 (de) Zusammensetzung zur erhoehung des blutdrucks.
MD1716C2 (ro) Utilizare a melatoninei pentru tratamentul pacienţilor dependenţi de benzodiazepine
KR890007728A (ko) 진통제 제조방법
KR890015746A (ko) 메게스트롤 아세테이트로 aids 악액질을 치료하는 방법
DE3650368D1 (de) Verwendung von Depogen zur Behandlung von eingeschränktem Blutkreislauf.
EA199901103A1 (ru) Антивирусный препарат для инъекций
KR960003718A (ko) 말초신경병 및 중추신경변성병의 치료에 유용한 의약의 제조를 위한 이펜프로딜 및 그 부분입체이성질체의 이용
FR2616327B3 (fr) Melange de plantes medicinales a titre de medicament pour le traitement des ulceres et des gastrites chroniques
KR900701311A (ko) 재조합 사람 α-인터페론을 병소내로 투여하여 편평세포 암을 치료하는 방법

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee